Metrika članka

  • citati u SCindeksu: [2]
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:13
  • preuzimanja u poslednjih 30 dana:11
članak: 1 od 1  
Engrami
2007, vol. 29, br. 1-2, str. 87-105
jezik rada: srpski
vrsta rada: pregledni članak

Komorbiditet bolesti zavisnosti i mentalnih poremećaja - konceptualni modeli i terapijske implikacije
Univerzitet u Beogradu, Medicinski fakultet, Klinički centar Srbije

e-adresa: olivukovic@gmail.com

Sažetak

Prema savremenom shvatanju adikcija predstavlja proces kojem prethode upotreba i zloupotreba psihoaktivne supstance, a karakterišu je maladaptivni bihejvioralni obrasci koji vremenom sve više dominiraju motivacionom hijerarhijom individue. Navedena bihejvioralna alteracija značajno doprinosi razvoju disfunkcionalnosti u različitim sferama funkcionisanja i pojavi različitih telesnih i mentalnih poremećaja. Dakle, zavisnici gotovo po pravilu manifestuju psihijatrijsku fenomenologiju. U dijagnostičkoj psihijatrijskoj praksi, posebna pažnja posvećuje se upravo diferencijaciji između primarnog psihijatrijskog poremećaja i psihijatrijskih simptoma uzrokovanih opštemedicinskim stanjem ili upotrebom alkohola i/ili psihoaktivnih supstanci. U radu su navedeni modeli kojim se tumači priroda odnosa između tih poremećaja i date su osnovne smernice za efikasan tretman pacijenata sa dvojnom dijagnozom.

Ključne reči

Reference

Addington, J., Guebaly, N., Campbell, W., Hodgins, D.C., Addington, D. (1998) Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry, 155(7): 974-6
Andreasson, S., Allebeck, P., Engstrom, A., Rydberg, U. (1988) Cannabis and schizophrenia. Lancet, 1(8592): 1000-1
Andrews, G. (1996) Comorbidity and the general neurotic syndrome. Br J Psychiatry Suppl, (30): 76-84
Andrews, G., Stewart, G., Allen, R., Henderson, A.S. (1990) The genetics of six neurotic disorders: A twin study. J Affect Disord, 19(1): 23-9
Ballenger, J.C., Goodwin, F.K., Major, L.F., Brown, G.L. (1979) Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry, 36(2): 224-7
Batel, P. (2000) Addiction and schizophrenia. Eur Psychiatry, 15(2): 115-22
Berkson, J. (1946) Limitation of the application of the 4-fold table analysis to hospital data. Biometrics, 2, str. 47-53
Blazer, D. (1995) Mood disorders: Epidemiology. u: Kaplan H., B.Sadock [ur.] Comprehensive Textbook of Psychiatry, Baltimore, MA: Williams and Wilkins, IV ed., vol. I, str. 1079-1089
Boyle, O.M., Brandon, E.A. (1998) Suicide attempts, substance abuse, and personality. J Subst Abuse Treat, 15(4): 353-6
Caron, C., Rutter, M. (1991) Comorbidity in child psychopathology: Concepts, issues and research strategies. J Child Psychol Psychiatry, 32(7): 1063-80
Chambers, R.A., Krystal, J.H., Self, D.W. (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry, 50(2): 71-83
Chaudry, H.R., Moss, H.B., Bashir, A., Suliman, T. (1991) Cannabis psychosis following bhang ingestion. Br J Addict, 86(9): 1075-81
Comings, D.E., Gade, R., Wu, S., Chiu, C., Dietz, G., Muhleman, D., Saucier, G., Ferry, L., Rosenthal, R.J., Lesieur, H.R., Rugle, L.J., MacMurray, P. (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry, 2(1): 44-56
Comings, D.E., Ferry, L., Bradshaw-Robinson, S., Burchette, R., Chiu, C., Muhleman, D. (1996) The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking. Pharmacogenetics, 6(1): 73-9
Copersino, M.L., Serper, M.R. (1998) Comorbidity of schizophrenia and cocaine abuse: Phenomenology and treatment. Medscape Mental Health, 3(2):6
Dean, B., Sundram, S., Bradbury, R., Scarr, E., Copolov, D. (2001) Studies on [3H]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience, 103(1): 9-15
Decina, P., Caracci, G., Sandik, R., Berman, W., Mukherjee, S., Scapicchio, P. (1990) Cigarette smoking and neuroleptic-induced parkinsonism. Biol Psychiatry, 28(6): 502-8
Dinan, T.G. (1994) Glucocorticoids and the genesis of depressive illness: A psychobiological model. Br J Psychiatry, 164(3): 365-71
Doris, A., Ebmeier, K., Shajahan, P. (1999) Depressive illness. Lancet, 354(9187): 1369-75
Farrell, M., Howes, S., Taylor, C., Lewis, G., Jenkins, R., Bebbington, P., Jarvis, M., Brugha, T., Gill, B., Meltzer, H. (2003) Substance misuse and psychiatric comorbidity: An overview of the OPCS National Psychiatric Morbidity Survey. Int Rev Psychiatry, 15(1-2): 43-9
Feinstein, A.R. (1970) The pre-therapeutic classification of the comorbidity in chronic disease. J Chronic Dis, 23, str. 455-486
Fergusson, D.M., Horwood, L.J., Lawton, J.M. (1990) Vulnerability to childhood problems and family social background. J Child Psychol Psychiatry, 31(7): 1145-60
Fergusson, D.M., Horwood, L.J., Lynskey, M.T. (1994) Parental separation, adolescent psychopathology, and problem behaviors. J Am Acad Child Adolesc Psychiatry, 33(8): 1122-31; discussion 1131-3
Fergusson, D.M., Lynskey, M.T., Horwood, L.J. (1996) Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds. Arch Gen Psychiatry, 53(11): 1043-7
Fils-Aime, M.L., Eckardt, M.J., George, D.T., Brown, G.L., Mefford, I., Linnoila, M. (1996) Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. Arch Gen Psychiatry, 53(3): 211-6
Francis, L. (1996) The relationship between Eysenck's personality factors and attitude towards substance use among 13-15-year-olds. Personality and Individual Differences, 21(5): 633-40
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M.C., i dr. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA, 94(2): 587-92
Gastfriend, D.R., Lillar, P. (1998) Anxiety disorders. u: Graham A.W., Schultz T.K. [ur.] Principles of Addiction Medicine, Chevy Chase, MD: American Society of Addiction Medicine, 2nd ed., 993-1006
Gawin, F.H., Ellinwood, E.H. (1988) Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med, 318(18): 1173-82
Gejman, P.V., Ram, A., Gelernter, J., Friedman, E., Cao, Q., Pickar, D., Blum, K., Noble, E.P., Kranzler, H.R., Malley, O.S. (1994) No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA, 271(3): 204-8
George, T.P., Vessicchio, J.C., Termine, A., Sahady, D.M., Head, C.A., Pepper, T.W., Kosten, T.R., Wexler, B.E. (2002) Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology, 26(1): 75-85
Greenfield, S.F., Weiss, R.D., Muenz, L.R., Vagge, L.M., Kelly, J.F., Bello, L.R., Michael, J. (1998) The effect of depression on return to drinking: A prospective study. Arch Gen Psychiatry, 55(3): 259-65
Grissom, G.R., Bragg, A. (1991) Addiction Severity Index: Experience in the field. Int J Addict, 26(1): 55-64
Guebaly, N. (1990) Substance abuse and mental disorders: The dual diagnoses concept. Can J Psychiatry, 35(3): 261-7
Hall, W., Solowij, N., Lemon, J. (1994) The Health and Social Consequences of Cannabis Use. u: Monograph Series No. 25, Canberra: Australian Government Publishing Service
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol, 6(4): 278-96
Heinz, A., Ragan, P., Jones, D.W., Hommer, D., Williams, W., Knable, M.B., Gorey, J.G., Doty, L., Geyer, C., Lee, K.S., Coppola, R., Weinberger, D.R., Linnoila, M. (1998) Reduced central serotonin transporters in alcoholism. Am J Psychiatry, 155(11): 1544-9
Hides, L., Lubman, D.I., Dawe, S. (2004) Models of co-occurring substance misuse and psychosis: Are personality traits the missing link?. Drug Alcohol Rev, 23(4): 425-32
Iqbal, N., Praag, H.M. (1995) The role of serotonin in schizophrenia. Eur Neuropsychopharmacol, 5 Suppl 11-23
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J.E., Day, R., Bertelsen, A. (1992) Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl, 20 1-97
Jašović-Gašić, M., Kunovac, J. (1990) Medikamentozna terapija alkoholizma. Engrami - časopis za kliničku psihijatriju, psihologiju i granične discipline, 12, str. 345-350
Jašović-Gašić, M., Marić, J., Banić, Z., Kunovac, J. (1990) Nozografija alkoholizma u savremenoj psihijatriji. Engrami - časopis za kliničku psihijatriju, psihologiju i granične discipline, 12:297-301
Jašović-Gašić, M., Miljević, Č., Crnobarić, C., Nikolić-Balkoski, G., Leposavić, Lj. (1996) Savremeni psihofarmakološki pristup tretmanu zavisnosti od psihoaktivnih supstanci. Alkoholizam
Johns, A. (2001) Psychiatric effects of cannabis. Br J Psychiatry, 178 116-22
Kendler, K.S., Neale, M.C., MacLean, C.J., Heath, A.C., Eaves, L.J., Kessler, R.C. (1993) Smoking and major depression: A causal analysis. Arch Gen Psychiatry, 50(1): 36-43
Kendler, K.S. (1998) Anna-Monika-Prize paper. Major depression and the environment: A psychiatric genetic perspective. Pharmacopsychiatry, 31(1): 5-9
Kendler, K.S., Kessler, R.C., Walters, E.E., MacLean, C., Neale, M.C., Heath, A.C., Eaves, L.J. (1995) Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry, 152(6): 833-42
Kessler, R. (1994) Building on the ECA: The National Comorbidity Survey and the Children’s ECA. Int J Meth Psychiatr Res, 4:81-94
Kessler, R.C., Price, R.H. (1993) Primary prevention of secondary disorders: A proposal and agenda. Am J Community Psychol, 21(5): 607-33
Kessler, R.C. (1995) Epidemiology of psychiatric comorbidity. u: Tsuang M.T. & M.Tohen, G. E. P. Zahner [ur.] Textbook in Psychiatric Epidemiology, New York: Wiley and Sons
Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., Kendler, K.S. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry, 51(1): 8-19
Kessler, R.C., Foster, C.L., Saunders, W.B., Stang, P.E. (1995) Social consequences of psychiatric disorders, I: Educational attainment. Am J Psychiatry, 152(7): 1026-32
Khantzian, E.J. (1997) The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harv Rev Psychiatry, 4(5): 231-44
Khantzian, E.J. (1985) The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry, 142(11): 1259-64
Klein, D.N., Riso, L.P. (1994) Psychiatric disorders: Problems of boundaries and comorbidity. u: Costello C.G. [ur.] Basic issues in psychopathology, New York: Guilford, pp 19- 66
Kleinman, P.H., Miller, A.B., Millman, R.B., Woody, G.E., Todd, T., Kemp, J., Lipton, D.S. (1990) Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis, 178(7): 442-7
Koob, G.F., le Moal, M. (1997) Drug abuse: Hedonic homeostatic dysregulation. Science, 278(5335): 52-8
Koob, G.F., le Moal, M. (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24(2): 97-129
Krebs, M.O., Sautel, F., Bourdel, M.C., Sokoloff, P., Schwartz, J.C., Olie, J.P., Loo, H., Poirier, M.F. (1998) Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Mol Psychiatry, 3(4): 337-41
Laakso, M.P., Vaurio, O., Savolainen, L., Repo, E., Soininen, H., Aronen, H.J., Tiihonen, J. (2000) A volumetric MRI study of the hippocampus in type 1 and 2 alcoholism. Behav Brain Res, 109(2): 177-86
Lerman, C., Caporaso, N., Main, D., Audrain, J., Boyd, N.R., Bowman, E.D., Shields, P.G. (1998) Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychol, 17(1): 56-62
Lerman, C., Caporaso, N.E., Audrain, J., Main, D., Bowman, E.D., Lockshin, B., Boyd, N.R., Shields, P.G. (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol, 18(1): 14-20
Leshner, A. (1998) Presentation at: American Methadone Treatment Association. u: Conference; September 1998, New York
Levin, F.R., Donovan, S.J. (1998) Attention deficit/hyperactivity disorder, intermittent explosive disorder, and eating disorders. u: Graham A.W., Schultz T.K. [ur.] Principles of Addiction Medicine, Chevy Chase: American Society of Addiction Medicine, Inc, 1029-1046
Linszen, D.H., Dingemans, P.M., Lenior, M.E. (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry, 51(4): 273-9
Lynskey, M.T., Fergusson, D.M., Horwood, L.J. (1998) The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. J Child Psychol Psychiatry, 39(7): 995-1005
Markou, A., Kosten, T.R., Koob, G.F. (1998) Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18(3): 135-74
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., Valverde, O. (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl), 159(4): 379-87
Mayfield, D., Mcleod, G., Hall, P. (1974) The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry, 131(10): 1121-3
Mcewen, B.S. (2000) Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology, 22(2): 108-24
Mclellan, A.T., Luborsky, L., Woody, G.E., Brien, O.C.P. (1980) An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Ment Dis, 168(1): 26-33
Merikangas, K.R. (1990) The genetic epidemiology of alcoholism. Psychol Med, 20(1): 11-22
Merikangas, K.R., Risch, N.J., Weissman, M.M. (1994) Comorbidity and co-transmission of alcoholism, anxiety and depression. Psychol Med, 24(1): 69-80
MICA Advisory Committee State of New Jersey (1992) Glossary of terms common in MICA treatment. Trenton, New Jersey: State of New Jersey
Miller, N.S., Summers, G.L., Gold, M.S. (1993) Cocaine dependence: Alcohol and other drug dependence and withdrawal characteristics. J Addict Dis, 12(1): 25-35
Miller, N.S., Dackis, C.A., Gold, M.S. (1987) The relationship of addiction, tolerance, and dependence to alcohol and drugs: A neurochemical approach. J Subst Abuse Treat, 4(3-4): 197-207
Minkoff, K. (1989) An integrated treatment model for dual diagnosis of psychosis and addiction. Hosp Community Psychiatry, 40(10): 1031-6
Minkoff, K., Drake, R.E., ur. (1991) Dual diagnosis of Major mental illness and substance disorder. San Francisco: Jossey-Bass
Mueser, K.T., Bellack, A.S., Blanchard, J.J. (1992) Comorbidity of schizophrenia and substance abuse: Implications for treatment. J Consult Clin Psychol, 60(6): 845-56
Neale, M.C., Kendler, K.S. (1995) Models of comorbidity for multifactorial disorders. Am J Hum Genet, 57(4): 935-53
Nemeroff, C.B. (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Mol Psychiatry, 1(4): 336-42
Newhouse, P.A., Hughes, J.R. (1991) The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addict, 86(5): 521-6
Noble, E.P., st Jeor, S.T., Ritchie, T., Syndulko, K., st Jeor, S.C., Fitch, R.J., Brunner, R.L., Sparkes, R.S. (1994) D2 dopamine receptor gene and cigarette smoking: A reward gene?. Med Hypotheses, 42(4): 257-60
Olincy, A., Ross, R.G., Young, D.A., Roath, M., Freedman, R. (1998) Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology, 18(3): 175-85
Os, J., Bak, M., Hanssen, M., Bijl, R.V., Graaf, R., Verdoux, H. (2002) Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol, 156(4): 319-27
Osher, F.C., Kofoed, L.L. (1989) Treatment of patients with psychiatric and psychoactive substance abuse disorders. Hosp Community Psychiatry, 40(10): 1025-30
Pomerleau, O.F., Pomerleau, C.S. (1984) Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation. Neurosci Biobehav Rev, 8(4): 503-13
Pope, H.G. (1979) Drug abuse and psychopathology. N Engl J Med, 301(24): 1341-2
Praag, H.M., Asnis, G.M., Kahn, R.S., Brown, S.L., Korn, M., Friedman, J.M., Wetzler, S. (1990) Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry, 157 723-34
Preisig, M., Fenton, B.T., Stevens, D.E., Merikangas, K.R. (2001) Familial relationship between mood disorders and alcoholism. Compr Psychiatry, 42(2): 87-95
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Goodwin, F.K. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19): 2511-8
Regier, D.A., Narrow, W.E., Rae, D.S. (1990) The epidemiology of anxiety disorders: The Epidemiologic Catchment Area (ECA) experience. J Psychiatr Res, 24 Suppl 2 3-14
Ries, R.K. (1993) The dually diagnosed patient with psychotic symptoms. J Addict Dis, 12(3): 103-22
Robertson, M.W., Leslie, C.A., Bennett, J.P. (1991) Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res, 538(2): 337-9
Rounsaville, B.J., Weissman, M.M., Kleber, H., Wilber, C. (1982) Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry, 39(2): 161-8
Roy, A., DeJong, J., Lamparski, D., George, T., Linnoila, M. (1991) Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables. Arch Gen Psychiatry, 48(5): 428-32
Rutter, M. (1987) Parental mental disorder as a psychiatric risk factor. u: R.Hales & A.Frances [ur.] Psychiatric Update: American Psychiatric Association: Annual Review, Washington: American Psychiatric Press, br. 6, pp 647-663
Sacco, K.A., Termine, A., Seyal, A., Dudas, M.M., Vessicchio, J.C., Krishnan-Sarin, S., Jatlow, P.I., Wexler, B.E., George, T.P. (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry, 62(6): 649-59
Sapolsky, R.M., Alberts, S.C., Altmann, J. (1997) Hypercortisolism associated with social subordinance or social isolation among wild baboons. Arch Gen Psychiatry, 54(12): 1137-43
Schuckit, M.A., Tipp, J.E., Bucholz, K.K., Nurnberger, J.I., Hesselbrock, V.M., Crowe, R.R., Kramer, J. (1997) The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction, 92(10): 1289-304
Schuckit, M.A., Tipp, J.E., Bergman, M., Reich, W., Hesselbrock, V.M., Smith, T.L. (1997) Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am J Psychiatry, 154(7): 948-57
Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Mori, N. (2003) Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry, 160(9): 1699-701
Shenk, J.W. (1999) America's altered states: When does legal relief of pain become illegal pursuit of pleasure. Harper's Magazine, 298:1788
Sinha, R. (2001) How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl), 158(4): 343-59
Stahl, S.M. (1998) Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action. J Clin Psychiatry, 59 Suppl 4 5-14
Swendsen, J.D., Merikangas, K.R. (2000) The comorbidity of depression and substance use disorders. Clin Psychol Rev, 20(2): 173-89
Talbott, J.A., Teague, J.W. (1969) Marihuana psychosis: Acute toxic psychosis associated with the use of Cannabis derivatives. JAMA, 210(2): 299-302
Tambs, K., Harris, J.R., Magnus, P. (1997) Genetic and environmental contributions to the correlation between alcohol consumption and symptoms of anxiety and depression. Results from a bivariate analysis of Norwegian twin data. Behav Genet, 27(3): 241-50
Tanda, G., Pontieri, F.E., di Chiara, G. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science, 276(5321): 2048-50
Teesson, M., Proudfoot, H., ur., National Drug and Alcohol Research Centre (2004) Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment. Canberra: DoHA
Tennant, F.S., Groesbeck, C.J. (1972) Psychiatric effects of hashish. Arch Gen Psychiatry, 27(1): 133-6
Thacore, V.R., Shukla, S.R. (1976) Cannabis psychosis and paranoid schizophrenia. Arch Gen Psychiatry, 33(3): 383-6
Tollefson, G.D. (1991) Anxiety and alcoholism: A serotonin link. Br J Psychiatry Suppl, (12): 34-9
True, W.R., Xian, H., Scherrer, J.F., Madden, P.A., Bucholz, K.K., Heath, A.C., Eisen, S.A., Lyons, M.J., Goldberg, J., Tsuang, M. (1999) Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry, 56(7): 655-61
Tsuang, M.T., Lyons, M.J., Meyer, J.M., Doyle, T., Eisen, S.A., Goldberg, J., True, W., Lin, N., Toomey, R., Eaves, L. (1998) Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry, 55(11): 967-72
Vaillant, G.E. (1998) Natural history of addiction and pathways to recovery. u: Graham A.W., Schultz T.K. [ur.] Principles of Addiction Medicine, Chevy Chase, MD: American Society of Addiction Medicine, 295-308, 2nd ed
Velez, C.N., Johnson, J., Cohen, P. (1989) A longitudinal analysis of selected risk factors for childhood psychopathology. J Am Acad Child Adolesc Psychiatry, 28(6): 861-4
Ventura, J., Nuechterlein, K.H., Subotnik, K.L., Gutkind, D., Gilbert, E.A. (2000) Symptom dimensions in recent-onset schizophrenia and mania: A principal components analysis of the 24-item Brief Psychiatric Rating Scale. Psychiatry Res, 97(2-3): 129-35
Volkow, N.D. (2001) Drug abuse and mental illness: Progress in understanding comorbidity. Am J Psychiatry, 158(8): 1181-3
Wallen, M., Weiner, H. (1988) The dually diagnosed patient in an inpatient chemical dependency treatment program. Alcohol Treat Q, 5(1/2):197-218
Weiss, F., Markou, A., Lorang, M.T., Koob, G.F. (1992) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res, 593(2): 314-8
Weiss, R.D., Griffin, M.L., Mirin, S.M. (1992) Drug abuse as self-medication for depression: An empirical study. Am J Drug Alcohol Abuse, 18(2): 121-9
Weissman, M., Livingston, B.M., Leaf, P., Flroio, L., Holzer, C. (1991) Affective disorders. u: L. Robins & D. Regier [ur.] Psychiatric Disorders in America, New York: MacMillan, pp. 53-80
Willner, P. (1997) The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol, 12 Suppl 3 S7-14
Winokur, G., Turvey, C., Akiskal, H., Coryell, W., Solomon, D., Leon, A., Mueller, T., Endicott, J., Maser, J., Keller, M. (1998) Alcoholism and drug abuse in three groups: Bipolar I, unipolars and their acquaintances. J Affect Disord, 50(2-3): 81-9
Yang, Y.K., Nelson, L., Kamaraju, L., Wilson, W., McEvoy, J.P. (2002) Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. Neuropsychopharmacology, 27(4), 684-686